Latest
By Henry Dubroff / Monday, July 9th, 2012 / Columns, Opinion / Comments Off on One SLO dad’s mission to save his daughter’s life, and the world
First, a word about what this column is not. It is not about a CEO, a big deal or a vast looming budget deficit. It is about a dad from San Luis Obispo who has embarked on a brave, if quixotic, quest to save his daughter’s life after she was diagnosed with cancer. Along the Read More →
Read More →
Latest
By Staff Report / Thursday, January 26th, 2012 / Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen to pay $1.2B for cancer drug firm
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Thousand Oaks-based Amgen is buying a leukemia drug maker for $1.2 billion in a bid to boost its blockbuster drug lineup. Amgen, the world’s largest biotech company, said Jan. 26 that it will purchase Maryland-based Micromet, maker of an experimental leukemia drug. Investors of Microment will Read More →
Read More →
